Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Revenue

Verrica Pharmaceuticals had revenue of $5.18M in the quarter ending June 30, 2024, with 2,744.51% growth. This brings the company's revenue in the last twelve months to $13.91M, up 61.61% year-over-year. In the year 2023, Verrica Pharmaceuticals had annual revenue of $5.12M, down -43.27%.

• Revenue (ttm): $13.91M
• Revenue Growth: +61.61%
• P/S Ratio: 6.37
• Revenue / Employee: $139,080
• Employees: 100
• Market Cap: 81.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.12M	-3.91M	-43.27%
Dec 31, 2022	9.03M	-2.97M	-24.73%
Dec 31, 2021	12.00M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.